About Apogen
Apogen is a Healthcare company based in Hyderabad (India) by Bhanu Prasad Kommineni, Tamma Raghava Srinivasa Reddy, and Sastry Tvpc. A CDMO specializing in novel pellet-based intermediates for generic drug formulations. It operates on a B2B model. The company has 33 employees. Its Indian entity Apogen Remedies Private Limited reported revenue of ₹8.63 Cr. Its focus areas include Pharmaceuticals, Drug Development and Generic Formulations. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Apogen a cdmo specializing in novel pellet-based intermediates for generic drug formulations through providing healthcare solutions, producing pharmaceutical products, drug development, and generic formulations. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Hyderabad, India
- Employees 33
- Founders Bhanu Prasad Kommineni, Tamma Raghava Srinivasa Reddy, Sastry Tvpc
- SectorsHealthcare
- Website apogen.in
- Social X Facebook
- Legal Name Apogen Remedies Private Limited
- Date of Incorporation 05 Jul, 2011
- Jurisdiction Siddipet, Telangana, India
- Annual Revenue₹8.63 Cr
FY 2025 · -35% YoY
- Net Profit₹1.40 Cr
FY 2025 · 16% margin
- EBITDA₹2.69 Cr
FY 2025 · 31% margin
- Employee Count33
Associated legal entities of Apogen
Apogen operates through Apogen Remedies Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Apogen Remedies Private Limited CIN U24232TG2011PTC075363 | Active | 05 Jul 2011 | Siddipet, Telangana | ₹8.6 Cr | 33 | 5 | View details |
Board of directors of Apogen Remedies Private Limited (Apogen)
Apogen Remedies Private Limited is the primary company behind Apogen. The board of Apogen Remedies Private Limited currently have 4 directors; the longest-serving is Bhanu Prasad Kommineni, appointed in 2011. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Bhanu Prasad Kommineni DIN 01408377 | Director | 05 Jul 2011 | 15 yrs 3 mo | Apogen Remedies Private Limited |
| Tamma Raghava Srinivasa Reddy DIN 02509720 | Director | 05 Jul 2011 | 15 yrs 3 mo | Apogen Remedies Private Limited |
| Vikram Bery DIN 02166843 | Director | 19 Jul 2019 | 7 yrs 3 mo | Apogen Remedies Private Limited |
| Bala Murali Krishna Thippabhotla DIN 02166860 | Director | 19 Jul 2019 | 7 yrs 3 mo | Apogen Remedies Private Limited |
People of Apogen
3 people are tracked at Apogen (3 in leadership); the tracked headcount is 33.
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
| Co-Founder | Leadership | |
Sastry Tvpc | Co-Founder | Leadership |
Complete people profiles for Apogen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Apogen
Figures of Apogen Remedies Private Limited, the primary company behind Apogen, for FY 2025. Revenue was ₹8.63 Cr (-35% year on year). Net profit was ₹1.40 Cr (16% margin). EBITDA was ₹2.69 Cr (31% margin). Revenue has grown at a compounded annual rate of +7% over three years and +930% over five years.
- ₹8.63 CrRevenue · FY 2025 · -35% YoY
- ₹1.40 CrNet profit · 16% margin
- ₹2.69 CrEBITDA · 31% margin
- ₹14.80 CrPaid-up capital
- 33Employees (provident fund records)
- +7%Revenue CAGR, 3 years
- +930%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Apogen Remedies Private Limited are on its company page.
Detailed financial statements for Apogen
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Apogen
Apogen has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Apogen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Apogen
The website of Apogen (apogen.in) receives about 1.7K visits a month.
- Monthly visits1.7K
▼ 3.7% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Apogen
Apogen is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Apogen has 33 employees.
The primary company behind Apogen, Apogen Remedies Private Limited, reported revenue of ₹8.63 Cr for FY 2025, down 35% year on year.
Apogen a cdmo specializing in novel pellet-based intermediates for generic drug formulations through providing healthcare solutions, producing pharmaceutical products, drug development, and generic formulations. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Apogen's top competitors include Laurus Labs, Symbiotec and SeQuent.
Apogen operates through Apogen Remedies Private Limited.
The legal entities of Apogen currently have 5 directors, including Vikram Bery, Bala Murali Krishna Thippabhotla, Abhishek Shukla and others.